We therefore hypothesized that T1DM mice exhibiting reduced myostatin mRNA expression would demonstrate improved skeletal muscle health resulting in increased insulin sensitivity and reduced blood glucose. This evidence concerns the gene INS and type 1 diabetes mellitus.